Personalized medicine, scientific revolution or self-serving illusion: viewpoint from EORTC-PAMM Group.
Personalized medicine has redefined oncology by tailoring treatments to molecular and clinical characteristics. However, despite remarkable advances in biomarker discovery and targeted therapy, the integration of pharmacological principles into precision oncology remains limited. The resulting discrepancy between biolo...